Satellos Bioscience Common Stock's current cash is $7.4M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), MSLE shows a current cash of $7.4M. That compares with $38M in the prior-year period — down 80.7% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MSLE's current cash is now $7.4M (was $38M) — a 80.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Satellos Bioscience Common Stock is outperforming or lagging.
Tracking MSLE's current cash over time shows whether Satellos Bioscience Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $7.4M That compares with $38M in the prior-year period — down 80.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Satellos Bioscience Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $7.4M) with ownership activity and broader fundamentals.